Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study

Background. Glucagon-like peptide 1 (GLP-1) bestows protective effects upon the cardiovascular system through direct cardiovascular interactions or by improvements to metabolic function. Both these effects are thought to be at least partly mediated by the GLP-1 receptor (GLP-1R). This case-controlle...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaowei Ma, Ran Lu, Nan Gu, Xiaowei Wei, Ge Bai, Jianwei Zhang, Ruifen Deng, Nan Feng, Jianping Li, Xiaohui Guo
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2018/1054192
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563046395936768
author Xiaowei Ma
Ran Lu
Nan Gu
Xiaowei Wei
Ge Bai
Jianwei Zhang
Ruifen Deng
Nan Feng
Jianping Li
Xiaohui Guo
author_facet Xiaowei Ma
Ran Lu
Nan Gu
Xiaowei Wei
Ge Bai
Jianwei Zhang
Ruifen Deng
Nan Feng
Jianping Li
Xiaohui Guo
author_sort Xiaowei Ma
collection DOAJ
description Background. Glucagon-like peptide 1 (GLP-1) bestows protective effects upon the cardiovascular system through direct cardiovascular interactions or by improvements to metabolic function. Both these effects are thought to be at least partly mediated by the GLP-1 receptor (GLP-1R). This case-controlled study investigated whether polymorphisms in the GLP-1R gene affect the risk of cardiovascular disease in type 2 diabetic patients in the Chinese Han population. Methods. Eleven haplotype-tagging single nucleotide polymorphisms (SNPs), distributed across 22 kb of the 39 kb GLP-1R gene, were selected and genotyped in diabetic patients from a Chinese Han population. Patients were classified based on the severity of coronary artery stenosis. Coronary artery stenosis was ≥50% in 394 patients (coronary artery disease- (CAD-) positive group), and coronary artery stenosis was <50% in 217 patients (control group). Allele and genotype frequencies were compared between the two groups at all 11 SNPs. Results. When considered in recessive inheritance mode, patients with the GG genotype at rs4714210 had a lower CAD risk than patients with other genotypes (OR = 0.442, 95% CI = 0.258–0.757, p=0.002), even when other known CAD risk factors were taken into account (ORa = 0.440, 95% CIa = 0.225–0.863, pa=0.017). In additive inheritance mode, GG genotype carriers at rs4714210 exhibited a lower risk of CAD than AA carriers (ORa = 0.475, CIa = 0.232–0.970, pa=0.041). Conclusion. In type 2 diabetic patients from a Han Chinese population, some variations in the GLP-1R gene were associated with a lower risk of developing CAD.
format Article
id doaj-art-aee620716ce74f218240d492b9c2c6ba
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-aee620716ce74f218240d492b9c2c6ba2025-02-03T01:21:08ZengWileyJournal of Diabetes Research2314-67452314-67532018-01-01201810.1155/2018/10541921054192Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control StudyXiaowei Ma0Ran Lu1Nan Gu2Xiaowei Wei3Ge Bai4Jianwei Zhang5Ruifen Deng6Nan Feng7Jianping Li8Xiaohui Guo9Department of Endocrinology, Peking University First Hospital, Beijing, ChinaDepartment of Endocrinology, Peking University First Hospital, Beijing, ChinaDepartment of Endocrinology, Peking University First Hospital, Beijing, ChinaDepartment of Endocrinology, Peking University First Hospital, Beijing, ChinaDepartment of Endocrinology, Peking University First Hospital, Beijing, ChinaDepartment of Endocrinology, Peking University First Hospital, Beijing, ChinaDepartment of Endocrinology, Peking University First Hospital, Beijing, ChinaDepartment of Endocrinology, Peking University First Hospital, Beijing, ChinaDepartment of Cardiovascular, Peking University First Hospital, Beijing, ChinaDepartment of Endocrinology, Peking University First Hospital, Beijing, ChinaBackground. Glucagon-like peptide 1 (GLP-1) bestows protective effects upon the cardiovascular system through direct cardiovascular interactions or by improvements to metabolic function. Both these effects are thought to be at least partly mediated by the GLP-1 receptor (GLP-1R). This case-controlled study investigated whether polymorphisms in the GLP-1R gene affect the risk of cardiovascular disease in type 2 diabetic patients in the Chinese Han population. Methods. Eleven haplotype-tagging single nucleotide polymorphisms (SNPs), distributed across 22 kb of the 39 kb GLP-1R gene, were selected and genotyped in diabetic patients from a Chinese Han population. Patients were classified based on the severity of coronary artery stenosis. Coronary artery stenosis was ≥50% in 394 patients (coronary artery disease- (CAD-) positive group), and coronary artery stenosis was <50% in 217 patients (control group). Allele and genotype frequencies were compared between the two groups at all 11 SNPs. Results. When considered in recessive inheritance mode, patients with the GG genotype at rs4714210 had a lower CAD risk than patients with other genotypes (OR = 0.442, 95% CI = 0.258–0.757, p=0.002), even when other known CAD risk factors were taken into account (ORa = 0.440, 95% CIa = 0.225–0.863, pa=0.017). In additive inheritance mode, GG genotype carriers at rs4714210 exhibited a lower risk of CAD than AA carriers (ORa = 0.475, CIa = 0.232–0.970, pa=0.041). Conclusion. In type 2 diabetic patients from a Han Chinese population, some variations in the GLP-1R gene were associated with a lower risk of developing CAD.http://dx.doi.org/10.1155/2018/1054192
spellingShingle Xiaowei Ma
Ran Lu
Nan Gu
Xiaowei Wei
Ge Bai
Jianwei Zhang
Ruifen Deng
Nan Feng
Jianping Li
Xiaohui Guo
Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study
Journal of Diabetes Research
title Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study
title_full Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study
title_fullStr Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study
title_full_unstemmed Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study
title_short Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study
title_sort polymorphisms in the glucagon like peptide 1 receptor glp 1r gene are associated with the risk of coronary artery disease in chinese han patients with type 2 diabetes mellitus a case control study
url http://dx.doi.org/10.1155/2018/1054192
work_keys_str_mv AT xiaoweima polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy
AT ranlu polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy
AT nangu polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy
AT xiaoweiwei polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy
AT gebai polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy
AT jianweizhang polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy
AT ruifendeng polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy
AT nanfeng polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy
AT jianpingli polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy
AT xiaohuiguo polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy